Literature DB >> 22652318

V-ATPases in osteoclasts: structure, function and potential inhibitors of bone resorption.

A Qin1, T S Cheng, N J Pavlos, Z Lin, K R Dai, M H Zheng.   

Abstract

The vacuolar-type H(+)-ATPase (V-ATPase) proton pump is a macromolecular complex composed of at least 14 subunits organized into two functional domains, V(1) and V(0). The complex is located on the ruffled border plasma membrane of bone-resorbing osteoclasts, mediating extracellular acidification for bone demineralization during bone resorption. Genetic studies from mice to man implicate a critical role for V-ATPase subunits in osteoclast-related diseases including osteopetrosis and osteoporosis. Thus, the V-ATPase complex is a potential molecular target for the development of novel anti-resorptive agents useful for the treatment of osteolytic diseases. Here, we review the current structure and function of V-ATPase subunits, emphasizing their exquisite roles in osteoclastic function. In addition, we compare several distinct classes of V-ATPase inhibitors with specific inhibitory effects on osteoclasts. Understanding the structure-function relationship of the osteoclast V-ATPase may lead to the development of osteoclast-specific V-ATPase inhibitors that may serve as alternative therapies for the treatment of osteolytic diseases.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22652318     DOI: 10.1016/j.biocel.2012.05.014

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  53 in total

1.  Bivariate Genome-Wide Association Study Implicates ATP6V1G1 as a Novel Pleiotropic Locus Underlying Osteoporosis and Age at Menarche.

Authors:  Li-Jun Tan; Zhuo-Er Wang; Ke-Hao Wu; Xiang-Ding Chen; Hu Zhu; Shan Lu; Qing Tian; Xiao-Gang Liu; Christopher J Papasian; Hong-Wen Deng
Journal:  J Clin Endocrinol Metab       Date:  2015-08-27       Impact factor: 5.958

Review 2.  Regulation of luminal acidification by the V-ATPase.

Authors:  Sylvie Breton; Dennis Brown
Journal:  Physiology (Bethesda)       Date:  2013-09

3.  Andrographolide suppresses RANKL-induced osteoclastogenesis in vitro and prevents inflammatory bone loss in vivo.

Authors:  Z J Zhai; H W Li; G W Liu; X H Qu; B Tian; W Yan; Z Lin; T T Tang; A Qin; K R Dai
Journal:  Br J Pharmacol       Date:  2014-02       Impact factor: 8.739

4.  Support of bone mineral deposition by regulation of pH.

Authors:  Harry C Blair; Quitterie C Larrouture; Irina L Tourkova; Li Liu; Jing Hao Bian; Donna Beer Stolz; Deborah J Nelson; Paul H Schlesinger
Journal:  Am J Physiol Cell Physiol       Date:  2018-07-25       Impact factor: 4.249

Review 5.  Sclerosing bone dysplasias: leads toward novel osteoporosis treatments.

Authors:  Igor Fijalkowski; Eveline Boudin; Geert Mortier; Wim Van Hul
Journal:  Curr Osteoporos Rep       Date:  2014-09       Impact factor: 5.096

Review 6.  Modulation of osteoclast differentiation and bone resorption by Rho GTPases.

Authors:  Heiani Touaitahuata; Anne Blangy; Virginie Vives
Journal:  Small GTPases       Date:  2014-03-10

7.  Biological characterization of the hygrobafilomycin antibiotic JBIR-100 and bioinformatic insights into the hygrolide family of natural products.

Authors:  Evelyn M Molloy; Jonathan I Tietz; Patricia M Blair; Douglas A Mitchell
Journal:  Bioorg Med Chem       Date:  2016-05-14       Impact factor: 3.641

Review 8.  Contribution of acidic extracellular microenvironment of cancer-colonized bone to bone pain.

Authors:  Toshiyuki Yoneda; Masahiro Hiasa; Yuki Nagata; Tatsuo Okui; Fletcher White
Journal:  Biochim Biophys Acta       Date:  2015-02-14

9.  Decreased sensory nerve excitation and bone pain associated with mouse Lewis lung cancer in TRPV1-deficient mice.

Authors:  Hiroki Wakabayashi; Satoshi Wakisaka; Toru Hiraga; Kenji Hata; Riko Nishimura; Makoto Tominaga; Toshiyuki Yoneda
Journal:  J Bone Miner Metab       Date:  2017-05-17       Impact factor: 2.626

Review 10.  Recent advances in osteoclast biology.

Authors:  Takehito Ono; Tomoki Nakashima
Journal:  Histochem Cell Biol       Date:  2018-02-01       Impact factor: 4.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.